0 CHECKOUT

Rosacea - Pipeline Review, H1 2015

  • ID: 3266291
  • April 2015
  • 94 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Celgene Corporation
  • Cutanea Life Sciences
  • Dermira Inc.
  • Kasiak Research Pvt. Ltd.
  • RestorGenex Corporation
  • MORE

Rosacea - Pipeline Review, H1 2015

Summary

This, ‘Rosacea - Pipeline Review, H1 2015’, provides an overview of the Rosacea’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Rosacea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rosacea and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Celgene Corporation
  • Cutanea Life Sciences
  • Dermira Inc.
  • Kasiak Research Pvt. Ltd.
  • RestorGenex Corporation
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Rosacea Overview
Therapeutics Development
Pipeline Products for Rosacea - Overview
Pipeline Products for Rosacea - Comparative Analysis
Rosacea - Therapeutics under Development by Companies
Rosacea - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Rosacea - Products under Development by Companies
Rosacea - Companies Involved in Therapeutics Development
Allergan, Inc.
Amorepacific Corporation
Celgene Corporation
Celtaxsys, Inc.
Cutanea Life Sciences
Delenex Therapeutics AG
Dermira Inc.
Foamix Pharmaceuticals Ltd.
Hovione FarmaCiencia SA
Kasiak Research Pvt. Ltd.
Merz Pharma GmbH & Co. KgaA
Promius Pharma, LLC
RestorGenex Corporation
TWi Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Rosacea - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AC-701 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ACUD-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
apremilast - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CTX-4430 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DLX-1008 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DRM-02 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GM-1111 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
incobotulinumtoxin A - Drug Profile
Product Description
Mechanism of Action
R&D Progress
minocycline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
minocycline Gel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
omiganan pentahydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
oxymetazoline hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
P-529 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PAC-14028 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PDI-320 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Refaglo - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SIG-990 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Cancer, Rosacea and Psoriasis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tetracycline MR - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rosacea - Recent Pipeline Updates
Rosacea - Dormant Projects
Rosacea - Discontinued Products
Rosacea - Product Development Milestones
Featured News & Press Releases
Apr 17, 2014: Treatment for Facial Redness Associated With Rosacea Now Available in the UK
Feb 26, 2014: mirvaso the first and only treatment targeting the facial redness of rosacea approved by the european commission
Jan 29, 2014: Galderma Announces the Publication of Positive Results of the Long-Term Study of Mirvaso Gel for Treatment of Persistent Erythema of Rosacea
Dec 20, 2013: Galderma Receives CHMP Positive Opinion For Mirvaso
Sep 27, 2013: Galderma Announces Availability of Mirvaso (brimonidine) Topical Gel, 0.33%
Aug 26, 2013: Galderma Receives FDA Approval of Mirvaso
Jul 08, 2013: Signum Dermalogix Investigational New Drug Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
Mar 16, 2012: Galderma Completes Phase III Trials Of Investigational Drug Targeting Facial Erythema Of Rosacea
Oct 20, 2011: Galderma Announces Positive Phase IIb Results For Investigational Compound Targeting Redness Of Rosacea
Aug 15, 2011: Argyle Therapeutics Receives Phase II SBIR Grant To Develop SIG990
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Rosacea, H1 2015
Number of Products under Development for Rosacea - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Rosacea - Pipeline by Allergan, Inc., H1 2015
Rosacea - Pipeline by Amorepacific Corporation, H1 2015
Rosacea - Pipeline by Celgene Corporation, H1 2015
Rosacea - Pipeline by Celtaxsys, Inc., H1 2015
Rosacea - Pipeline by Cutanea Life Sciences, H1 2015
Rosacea - Pipeline by Delenex Therapeutics AG, H1 2015
Rosacea - Pipeline by Dermira Inc., H1 2015
Rosacea - Pipeline by Foamix Pharmaceuticals Ltd., H1 2015
Rosacea - Pipeline by Hovione FarmaCiencia SA, H1 2015
Rosacea - Pipeline by Kasiak Research Pvt. Ltd., H1 2015
Rosacea - Pipeline by Merz Pharma GmbH & Co. KgaA, H1 2015
Rosacea - Pipeline by Promius Pharma, LLC, H1 2015
Rosacea - Pipeline by RestorGenex Corporation, H1 2015
Rosacea - Pipeline by TWi Pharmaceuticals, Inc., H1 2015
Rosacea - Pipeline by Valeant Pharmaceuticals International, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Rosacea Therapeutics - Recent Pipeline Updates, H1 2015
Rosacea - Dormant Projects, H1 2015
Rosacea - Dormant Projects (Contd..1), H1 2015
Rosacea - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for Rosacea, H1 2015
Number of Products under Development for Rosacea - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Allergan, Inc.
Amorepacific Corporation
Celgene Corporation
Celtaxsys, Inc.
Cutanea Life Sciences
Delenex Therapeutics AG
Dermira Inc.
Foamix Pharmaceuticals Ltd.
Hovione FarmaCiencia SA
Kasiak Research Pvt. Ltd.
Merz Pharma GmbH & Co. KgaA
Promius Pharma, LLC
RestorGenex Corporation
TWi Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Merck & Co., Inc.
  • Celgene Corporation
  • GlaxoSmithKline PLC
  • Genentech, Inc.
  • Johnson & Johnson Services, Inc.
  • ViiV Healthcare